Clin2
NCT07072910Possibly a fitRecruiting

Cabergoline for migraine prevention

Migraine

Treatments studied

Part of Brain & nervous system clinical trials.

This trial tests if a once-weekly medication called cabergoline can reduce how often you get migraine headaches. It is for adults who have between 4 and 14 migraine days per month.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
150 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have been diagnosed with episodic migraine (between 4 and 14 migraine days per month for the last 3 months).
  • You have not changed your migraine prevention medications in the last 3 months.
  • You do not have chronic migraine (15 or more headache days per month) or other frequent headache types.
  • You do not have a history of heart valve disease, lung, or abdominal disorders.
  • You will use reliable birth control if you or your partner could become pregnant.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07071506Recruiting
New tools to track migraine prevention

This study tests new ways to monitor how well preventive migraine treatments are working. It is for people with chronic migraine who may be starting or already using preventive medications.

Aarhus C, Denmark
NCT07451769Recruiting
Testing a new drug target for migraine relief

This trial tests a substance that activates adrenomedullin receptors, which may be a new way to treat migraines. It may help people who have migraines without aura and aren't on preventive migraine medications.

Glostrup Municipality
NCT06968429Not yet recruiting
Oral butylphthalide capsules for preventing migraine attacks

This trial tests whether an oral capsule called butylphthalide (also known as NBP) can help prevent migraine attacks in adults who get them regularly. If you have migraines 4–14 days per month, this study may offer a new preventive option.

NCT07646613Recruiting· Phase 2
Testing an inhaled migraine medicine for quick relief

This study tests a new inhaled powder form of a migraine medication called dihydroergotamine (DHE) to see if it safely and effectively stops migraine attacks. If you have frequent migraines, this trial might offer you a new treatment option to try.

Phoenix, Arizona
NCT06808230Recruiting
Cocoa extract for migraine prevention study

This trial tests whether taking cocoa extract daily can help prevent migraine attacks in people with 4-14 migraines per month. You'll use a phone app to track your headaches and take either cocoa extract or a placebo.

Boston, Massachusetts
NCT06904287Recruiting· Phase 3
Magnesium for migraine treatment in adults

This trial tests if adding magnesium to a standard migraine medication (prochlorperazine) helps treat migraines more effectively. It could be a good option for adults with migraines who haven't taken these drugs recently.

Oak Lawn, Illinois

Hear when a new Migraine trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.